Salicylic Acid

Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.

Clobetasol Propionate (0.05%) and Salicylic Acid (3% or 6%) ointment is a potent keratolytic-corticosteroid combination for hyperkeratotic dermatoses. Clobetasol is an ultra-high potency (Class I) topical corticosteroid that produces rapid vasoconstriction, anti-inflammatory, and immunosuppressive actions, while salicylic acid dissolves the intercellular cement of the stratum corneum, desquamating thick adherent scales and enhancing the penetration of clobetasol into the dermis. Indicated for chronic plaque psoriasis, palmoplantar psoriasis, lichen planus, hypertrophic lichen simplex chronicus, and severe hyperkeratotic eczema.

Clobetasol Propionate (0.05%) and Salicylic Acid (3% or 6%) ointment is a potent keratolytic-corticosteroid combination for hyperkeratotic dermatoses. Clobetasol is an ultra-high potency (Class I) topical corticosteroid that produces rapid vasoconstriction, anti-inflammatory, and immunosuppressive actions, while salicylic acid dissolves the intercellular cement of the stratum corneum, desquamating thick adherent scales and enhancing the penetration of clobetasol into the dermis. Indicated for chronic plaque psoriasis, palmoplantar psoriasis, lichen planus, hypertrophic lichen simplex chronicus, and severe hyperkeratotic eczema.

Coal Tar, Dithranol (Anthralin), and Salicylic Acid ointment is a classic triple keratoplastic and anti-mitotic anti-psoriatic compound. Coal tar exerts anti-proliferative and anti-pruritic actions; dithranol inhibits mitochondrial DNA synthesis in hyperplastic keratinocytes; and salicylic acid provides keratolysis. Indicated for subacute and chronic plaque psoriasis of the body and scalp.

Glycolic Acid (6%, 12% cream or face wash) is an alpha-hydroxy acid (AHA) derived from sugarcane. It weakens the cohesion of corneocytes in the lower stratum corneum, promoting gentle chemical exfoliation, stimulating dermal collagen synthesis, and accelerating cell turnover. Indicated for mild-to-moderate acne, photoaging, rough texture, post-acne hyperpigmentation, and keratosis pilaris.

Salicylic Acid 1% Foaming Facewash is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Salicylic Acid 3% powder is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Salicylic Acid 2% Foaming Facewash is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Para Aminobenzoic Acid100mg, Calcium Pant 100mg, Niacinamide12mg, L-Arginine50mg L-Cysteine50mg, DL-Methionine40mg, L-Lysine20mg, Zinc25mg, Inositol 10mg, Biotin10mg, Ferrous10mg, Copper2mg Tablets is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Azelaic Acid (10%, 20% cream) is a naturally occurring saturated dicarboxylic acid anti-acne and anti-rosacea agent. It inhibits DNA synthesis in Cutibacterium acnes, suppresses follicular hyperkeratinization (comedolytic), and competitively inhibits tyrosinase, reducing post-inflammatory hyperpigmentation without bleaching normal skin. Indicated for mild-to-moderate inflammatory acne vulgaris, papulopustular rosacea, and post-inflammatory hyperpigmentation/melasma.

Glycolic Acid (6%, 12% cream or face wash) is an alpha-hydroxy acid (AHA) derived from sugarcane. It weakens the cohesion of corneocytes in the lower stratum corneum, promoting gentle chemical exfoliation, stimulating dermal collagen synthesis, and accelerating cell turnover. Indicated for mild-to-moderate acne, photoaging, rough texture, post-acne hyperpigmentation, and keratosis pilaris.

Benzoic acid 6% and Salicylic acid 3% Ointment is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.